Most Profitable Biotechnology Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1AMGN Amgen Inc
6.72 B
(0.06)
 1.47 
(0.09)
2GILD Gilead Sciences
5.61 B
 0.29 
 1.31 
 0.38 
3GMAB Genmab AS
4.35 B
(0.22)
 1.55 
(0.33)
4ROIV Roivant Sciences
4.23 B
 0.08 
 1.51 
 0.12 
5REGN Regeneron Pharmaceuticals
3.95 B
(0.35)
 1.67 
(0.59)
6VRTX Vertex Pharmaceuticals
3.62 B
 0.04 
 1.61 
 0.07 
7BIIB Biogen Inc
1.16 B
(0.24)
 1.29 
(0.30)
8HLN Haleon plc
1.05 B
(0.07)
 0.95 
(0.07)
9INCY Incyte
597.6 M
 0.20 
 2.19 
 0.43 
10ALKS Alkermes Plc
355.76 M
 0.06 
 2.31 
 0.14 
11HALO Halozyme Therapeutics
281.59 M
 0.01 
 2.88 
 0.02 
12NBIX Neurocrine Biosciences
249.7 M
(0.06)
 2.87 
(0.18)
13EXEL Exelixis
207.76 M
 0.20 
 2.38 
 0.49 
14NWBO Northwest Biotherapeutics
179.13 M
(0.04)
 3.97 
(0.17)
15VYGR Voyager Therapeutics
132.33 M
 0.03 
 4.77 
 0.17 
16MDXG MiMedx Group
67.44 M
 0.10 
 3.33 
 0.33 
17GRFS Grifols SA ADR
59.31 M
 0.14 
 3.24 
 0.45 
18PROC Procaps Group SA
52.2 M
(0.15)
 7.00 
(1.06)
19PROCW Procaps Group SA
52.2 M
 0.20 
 215.05 
 43.85 
20SPRO Spero Therapeutics
22.81 M
 0.07 
 2.73 
 0.19 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.